MCP简体中文Upgrade
Market/Categories/Business Specialist/Vysioneer

Independent product intelligence · Worldwide · 2026-05-01 → 2026-07-31

Vysioneervysioneer.com

Vysioneer offers AI-powered treatment efficacy assessment for oncology clinical trials, analyzing all lesions to predict outcomes and accelerate trial timelines.

Business Specialistvysioneer.comTracked since 2026-08-211 discovery source
329Backlinks
244Referring domains
13Domain authority
-10.5%Referring domains · 90 days

Authority & distribution

How strong is Vysioneer’s web footprint?

Backlinks measure accumulated distribution; referring domains show how broadly that authority is spread. Both are observable on the open web, so both are published for every product here.

Backlinks

329Current snapshot

Referring domains

244Current snapshot

Authority

13Domain authority · category median 22

90-day move

-10.5%Referring domains, last 90 days
At 13, Vysioneer sits below the 22 median for its category.

Trajectory · Pro

The counts above are the latest of 370 daily observations. The curve through them is on the full profile.

See the trajectoryOpen the full profile

AI referral visibility

Which AI assistants are already sending Vysioneer traffic?

Measured · Pro

Measured for this product: AI referral traffic.

Unlock this profileOpen the full profile

Product profile

What Vysioneer is selling.

Traffic makes more sense when you can connect it to the actual product promise.

“Vysioneer”

Vysioneer offers AI-powered treatment efficacy assessment for oncology clinical trials, analyzing all lesions to predict outcomes and accelerate trial timelines.

Business SpecialistSeen 2026-08-21 → 2026-08-21Coverage tier C

What we have measured

4 of 8 signal groups are available for this product: identity, authority and backlinks, AI referrals, search demand.

Not measured for this domain: traffic and engagement, audience demographics, country distribution, acquisition mix. Those sections are left out of the page rather than filled with estimates.

Canonical website: https://www.vysioneer.com

Observed across 1 discovery source.

Research questions

What the evidence answers about Vysioneer.

Every answer is tied to a source we collected, and the questions with no evidence behind them are left unanswered rather than guessed.

What problem does Vysioneer aim to solve in oncology?

Vysioneer addresses the challenge of tumor heterogeneity in cancer treatment, where patients develop a mixture of shrinking, stable, and growing tumors. This heterogeneity is described as a significant obstacle to personalized medicine and understanding long-term treatment outcomes. The platform aims to make oncology trials smaller and faster by analyzing all lesions.

Who is the target user or organization for Vysioneer?

Vysioneer is designed for entities involved in oncology clinical trials, such as pharmaceutical companies and research institutions. The product collaborates with major industry players like Pfizer, as noted in its publications.

What are the key features or capabilities offered by Vysioneer?

Vysioneer offers AI Information to extract all-lesion features beyond current response evaluation criteria. It also provides AI Prediction to explore all-lesion biomarkers that predict treatment outcomes. The platform is an AI-powered cloud service for treatment efficacy assessment.

What is Vysioneer used for, and in what situations?

Vysioneer is used for AI-powered treatment efficacy assessment in oncology clinical trials. It analyzes all lesions to confirm treatment outcomes and predict results. The product is applied to accelerate trial timelines and is particularly useful in situations involving tumor heterogeneity.

What is Vysioneer?

Vysioneer is an AI-powered platform for oncology clinical trial treatment efficacy assessment. It uses artificial intelligence and cloud services to analyze lesions and predict treatment outcomes, aiming to make cancer care more accurate and efficient.

5 of 6 research questions are answered for this product. The rest need source evidence we have not collected yet, so they are left unanswered rather than guessed.

Behind the lock

Unlock full Vysioneer intelligence.

  • Backlink trajectoryThe figures above are the latest observation. The daily curve behind them holds 370.
  • AI referral detailHow much traffic assistants send.
  • Search structure and ranking depthOrganic against paid, brand against non-brand, and how many keywords rank in the top three against the long tail — which is what decides whether the demand is portable or tied to the name.
  • The rest of the marketPage through every leaderboard 100 rows at a time, put any five products side by side, and query the whole dataset over API / MCP.

Worldwide estimates · Data period 2026-05-01 → 2026-07-31. Figures are measured estimates intended for market research. Signals we have not measured for this domain are omitted, never estimated; a measured zero is still reported as zero. How this was measured